1.      American College of Rheumatology. 2024 American College of Rheumatology guideline for the screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2024.

2.      Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400-1412. doi:10.1002/art.40930

3.      Kavanaugh AF, Solomon DH; American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum. 2002;47(5):546-555. doi:10.1002/art.10558

4.      Morand EF, et al. Advances in the management of systemic lupus erythematosus. BMJ. 2023;383:e073980. Published 2023 Oct 26. doi:10.1136/bmj-2022-073980

5.      Nashi RA, Shmerling RH. Antinuclear antibody testing for the diagnosis of systemic lupus erythematosus. Med Clin North Am. 2021;105(2):387-396. doi:10.1016/j.mcna.2020.10.003

6.      Pennesi M, Benvenuto S. Lupus nephritis in children: novel perspectives. Medicina (Kaunas). 2023;59(10):1841. Published 2023 Oct 16. doi:10.3390/medicina59101841

7.      Peyronel F, Rossi GM, Palazzini G, et al. Early-onset lupus nephritis. Clin Kidney J. 2024;17(8):sfae212. Published 2024 Jul 13. doi:10.1093/ckj/sfae212

8.      Rovin BH, Ayoub IM, Chan TM, et al. Executive summary of the KDIGO 2024 clinical practice guideline for the management of lupus nephritis. Kidney Int. 2024;105(1):31-34. doi:10.1016/j.kint.2023.09.001

9.      Sada KE, Makino H. Usefulness of ISN/RPS classification of lupus nephritis. J Korean Med Sci. 2009;24(Suppl 1):S7-S10. doi:10.3346/jkms.2009.24.S1.S7

10.  Sammaritano LR, Askanase A, Bermas BL, et al. 2025 American College of Rheumatology guideline for the treatment of systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2025. Published online Nov 3. doi:10.1002/acr.25690

11.  Su X, Yu H, Lei Q, et al. Systemic lupus erythematosus: pathogenesis and targeted therapy. Mol Biomed. 2024;5(1):54. Published 2024 Oct 30. doi:10.1186/s43556-024-00217-8

12.  Tan EM, Feltkamp TE, Smolen JS, et al. Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum. 1997;40(9):1601-1611. doi:10.1002/art.1780400909

13.  Trindade VC, et al. An update on the management of childhood-onset systemic lupus erythematosus. Paediatr Drugs. 2021;23(4):331-347. doi:10.1007/s40272-021-00457-z